Think management might be leaning towards your view Coto - hence...

First 35 Last

Share
Profile

Follow
tbirdsrgo

13,599 Posts.

469

16/09/22

22:58

Post #: 63749087
Share

Originally posted by coto: ↑

Yes exactly, I acknowledge what you and dazed are speaking about, it seems the depths and widths of the RDT Li bearing pegmatites are more suited to the underground mining and following those channels that are still open at depth. It’s also dependent on Lithium pricing and all sorts of things whether it gets mined. Right now the sentiment is strong so clearly the market likes it regardless.

As with our early data and the changes close to the Ida fault line, it does appear the pegmatites are at a shallower depth due to the structural changes of the geology closer to the fault. Which is definitely positive when it comes to potential mining since it is a lot cheaper to get out of the ground! I would have to have a closer look at the geology and await further data from the RC drilling program but early indications seem good.

For example, in every drill hole (MAD181 - MAD187) except for MAD184, the pegmatite bands have come in relatively shallow. Respectively, from depths of 40.5m, 10m, 12m, 40.5m, 14m and 50.5m. This is a different situation to what has unfolded in the RDT ground as these intersections are much deeper.

Obviously with everything that has happened to date, OzBlue has very negative views of management and SGQ, which I can definitely understand! It’s been a rough 2 years. However, I do appreciate Ozblues rhetoric and views as this poster has been correct quite often in their analysis. It would be great to have an opinion regarding the geological nature of the pegmatites and the potential here.

Expand

Think management might be leaning towards your view Coto - hence the RC driller?

They seem to be reasonably positive about shallower deposits compared to RDT - and I think - the extent of deposits.

When I compared ours with RDT I was thinking more in terms of the "system" so if they find something meaningful I will infer that we will follow them generally.

Clearly something about our holdings has put a spring in the steps of our management. Time will tell.

SGQ Price at posting: 3.2¢ Sentiment: None Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

There are more pages in this discussion • 3 more messages in this thread...

First 35 Last

Add SGQ (ASX) to my watchlist

(20min delay)
Last 3.3¢		Change -0.001(2.94%)		Mkt cap ! $37.01M

Open	High	Low	Value	Volume
3.3¢	3.3¢	3.3¢	$40.92K	1.240M

Buyers (Bids)

No.	Vol.	Price($)
9	3087854	3.2¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	58741	1

View Market Depth

No.	Vol.	Price($)
9	3087854	0.032
2	2611111	0.031
15	1632664	0.030
6	2474826	0.029
7	3115246	0.028

Price($)	Vol.	No.
0.033	100000	1
0.034	615927	2
0.035	1360370	4
0.036	1448775	3
0.037	1467297	4

Last trade - 10.37am 04/10/2024 (20 minute delay)

SGQ (ASX) Chart

Think management might be leaning towards your view Coto - hence...

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Think management might be leaning towards your view Coto - hence...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News